Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability

Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability

<b>Background/Objectives</b>: Gypenosides (Gps) are the main active compounds of <i>Gynostemma</i> and show promise in managing diabetes; nevertheless, the mechanism by which Gps exert anti-diabetic effects is still not fully understood. The aim of this study is to clarify th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rong Wang, Xue-Feng Liu, Kuan Yang, Li-Li Yu, Shao-Jing Liu, Na-Na Wang, Yun-Mei Chen, Ya-Qi Hu, Bei Qin
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Current Issues in Molecular Biology
Subjects:	gypenosides type 2 diabetes mellitus gut microbiota short-chain fatty acids bile acids
Online Access:	https://www.mdpi.com/1467-3045/47/7/515
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gypenosides alleviates MCT-induced pulmonary arterial hypertension in rats by targeting oxidative stress, inflammation, and apoptosis
by: Du Dan, et al.
Published: (2025-08-01)

Gypenoside ameliorates insulin resistance and hyperglycemia via the AMPK-mediated signaling pathways in the liver of type 2 diabetes mellitus mice
by: Mengxue Song, et al.
Published: (2022-09-01)

Gypenosides Attenuates CORT-Induced Ferroptosis via Inhibiting TNF-α/NF-κB Signaling Pathway in PC12 Cells
by: Lingling Dai, et al.
Published: (2025-05-01)

Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis
by: Chuanjian Yuan, et al.
Published: (2025-07-01)

Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer
by: Meiyu Liu, et al.
Published: (2025-05-01)

The role of gut microbiota‐derived metabolites in neuroinflammation
by: Lingjie Mu, et al.
Published: (2025-06-01)

Gypenoside XLIX inhibiting PI3K/AKT/FOXO1 signaling pathway mediated neuronal mitochondrial autophagy to improve patients with ischemic stroke
by: Yonglei Liu, et al.
Published: (2025-08-01)

Bile acid receptors regulate the role of intestinal macrophages in inflammatory bowel disease
by: Hongjie Yang, et al.
Published: (2025-06-01)

Mechanism of Pediococcus pentosaceus PP04 in alleviating high-fat diet caused hyperlipidemia via modulation of intestinal flora and it's metabolites
by: Yu Wang, et al.
Published: (2025-07-01)

Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota
by: Huanhuan Liu, et al.
Published: (2025-01-01)

Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats
by: Yewen Sun, et al.
Published: (2025-04-01)

Research Progress on the Interaction between Taurine Metabolism and the Gut Microbiota
by: YANG Xinyu, WU Qingjie, MI Shengquan, ZHANG Yanzhen, GUO Junxia
Published: (2025-02-01)

Lactobacillus plantarum CCFM1180 attenuates obesity induced by estrogen deficiency by activating estrogen receptor alpha in abdominal adipose tissue and regulating gut microbiota-derived metabolites
by: Qian Chen, et al.
Published: (2024-03-01)

Dihydroquercetin attenuated Prevotella copri-caused intestinal injury by modulating gut microbiota and bile acids in weaned piglets
by: Long Wang, et al.
Published: (2025-03-01)

The role of gut microbiota in metabolic regulation
by: Ekaterina N. Kravchuk, et al.
Published: (2016-11-01)

Dietary cholesterol impairs cognition via gut microbiota-derived deoxycholic acid in obese mice
by: Yan Liu, et al.
Published: (2025-12-01)

Bile acids affect intestinal barrier function through FXR and TGR5
by: Guangyao Song, et al.
Published: (2025-07-01)

Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism
by: Yujie Huang, et al.
Published: (2025-06-01)

Hyodeoxycholic acid modulates gut microbiota and bile acid metabolism to enhance intestinal barrier function in piglets
by: Jie Chong, et al.
Published: (2025-06-01)

Relationship between gut microbiota dysbiosis and bile acid in patients with hepatitis B-induced cirrhosis
by: Yannan Li, et al.
Published: (2025-08-01)

The potential of pomegranate peel supplementation in Yellow-feathered broilers: effects on growth performance, serum biochemistry, antioxidant capacity, intestinal health, intestinal microbiota, and duodenal mucosal metabolites
by: Wang Chen, et al.
Published: (2025-04-01)

Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes
by: Jae Won Lee, et al.
Published: (2022-12-01)

Significance of intestinal microbiota in implementing metabolic effects of bariatric surgery
by: Marina A. Berkovskaya, et al.
Published: (2021-03-01)

Sugarcane leaves-derived polyphenols alleviate metabolic syndrome and modulate gut microbiota of ob/ob mice
by: Li Sun, et al.
Published: (2024-03-01)

Correlation of the intestinal flora and its metabolites with the colonic transport function in functional constipation
by: Lunan Hu, et al.
Published: (2025-05-01)

Gut microbiota-mediated bile acid transformations regulate the transport of aflatoxin B1 from the intestine to the liver in piglets
by: Jiangdi Mao, et al.
Published: (2025-03-01)

Effects of supplementing bile acids on the production performance, fatty acid and bile acid composition, and gut microbiota in transition dairy cows
by: Lei Li, et al.
Published: (2025-06-01)

Portal bile acid composition and microbiota along the murine intestinal tract exhibit sex differences in physiology
by: François Reichardt, et al.
Published: (2025-12-01)

Gut microbial metabolites in depression: understanding the biochemical mechanisms
by: Giorgia Caspani, et al.
Published: (2019-09-01)

The role of intestinal microbiota in the development of dyslipidemia and cardiovascular disease risk
by: T. V. Bogoslav
Published: (2024-04-01)

Lactobacillus paragasseri HM018, Isolated from Human Milk, Improves Intestinal Metabolism in Germ-Free Mice Humanized with Gut Microbiota from Pregnant Women during Pregnancy
by: TIAN Xiaoyan, ZHAO Junying, LIU Yanpin, LIU Bin, ZHANG Zhenzhen, ZHAO Yujin, ZHAO Yanyan, YUAN Yuying, LIU Lu, WANG Yaru, QIAO Weicang, CHEN Lijun
Published: (2025-07-01)

Multifaceted Interactions Between Bile Acids, Their Receptors, and MASH: From Molecular Mechanisms to Clinical Therapeutics
by: Xuan Tang, et al.
Published: (2025-07-01)

Gut bacteria Prevotellaceae related lithocholic acid metabolism promotes colonic inflammation
by: Liping Chen, et al.
Published: (2025-01-01)

Exploring the Effects of Metabolites from Lactobacillus rhamnosus GM020 and Cyanidin-3-O-Glucoside on Differential Metabolites in the High-fat Diet Mice Liver Based on Metabolomics
by: Sihang WANG, et al.
Published: (2025-08-01)

Gut Microbiota in Primary Sarcopenia: Mechanisms and Potential Therapeutic Targets
by: Leshan Chen, et al.
Published: (2025-05-01)

Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
by: Andrea Martinez Aguirre, et al.
Published: (2022-12-01)

The gut microbiota changed by ketogenic diets contribute to glucose intolerance rather than lipid accumulation
by: Wei Li, et al.
Published: (2024-09-01)

Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
by: Xue Bai, et al.
Published: (2025-06-01)

Advances in research on the role of gut microbiota in the pathogenesis and precision management of gallstone disease
by: Ludong Tan, et al.
Published: (2025-06-01)

Gut-Microbiota-Driven Lipid Metabolism: Mechanisms and Applications in Swine Production
by: Shuqi Xiong
Published: (2025-04-01)